Literature DB >> 22200012

The Comparison of Outcome between Thromboaspiration and Aggressive Mechanical Clot Disruption in Treating Hyperacute Stroke Patients.

Hyun Goo Lee1, Jong Kook Rhim, Yoon Hee Kim, Seung Hun Sheen, Sung Han Oh, Bong Sub Chung.   

Abstract

OBJECTIVE: Stroke is the third leading cause of death in the Republic of Korea. Time is the most important factor in hyperacute stroke. Yet, there had been no protocol for mechanical thrombolysis. We have treated patients with hyperacute stroke by mechanical thrombolysis for 3 years. In current study, we analyzed the outcome of mechanical thrombolysis.
METHODS: From March 2008 to February 2011, 36 patients were treated with mechanical thrombolysis. Initially we treated the patients by aggressive mechanical clot disruption (AMCD) who were admitted within 6 hours after the symptom onset. If revascularization was not achieved, balloon angioplasty was performed, followed by stenting or temporary endovascular bypass was performed. The result in 15 cases was not so successful. Since then, we started using the thromboaspiration method as the first line treatment of the mechanical thrombolysis.
RESULTS: After using the thromboaspiration, we had better results in recanalization rate, modified Rankin Score (mRS) and reperfusion injury compared to AMCD. The recanalization rate was 80.85%, mRS is 2.85, and there was only 0.09% hemorrhagic formation.
CONCLUSION: Even though thromboaspiration is not statistically significant due to the limited numbers of patients enrolled in this study, we think it is a good way in mechanical thronbolysis for hyperacute stroke.

Entities:  

Keywords:  Acute; Aspiration; Mechanical; Stroke; Thrombolysis

Year:  2011        PMID: 22200012      PMCID: PMC3243833          DOI: 10.3340/jkns.2011.50.4.311

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  17 in total

1.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

Authors:  Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren
Journal:  Lancet       Date:  2007-01-27       Impact factor: 79.321

2.  Treating acute stroke patients with intravenous tPA. The OSF stroke network experience.

Authors:  D Z Wang; J A Rose; D S Honings; D J Garwacki; J C Milbrandt
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

3.  Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals.

Authors:  S D Reed; S C Cramer; D K Blough; K Meyer; J G Jarvik
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

4.  Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity.

Authors:  S C Johnston; L H Fung; L A Gillum; W S Smith; L M Brass; J H Lichtman; A N Brown
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

5.  Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke: a case-control study.

Authors:  T C Burns; G J Rodriguez; S Patel; H M Hussein; A L Georgiadis; K Lakshminarayan; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-10       Impact factor: 3.825

6.  Penumbra Stroke System as an "add-on" for the treatment of large vessel occlusive disease following thrombolysis: first results.

Authors:  Tobias Struffert; Martin Köhrmann; Tobias Engelhorn; Tim Nowe; Gregor Richter; Peter D Schellinger; Stefan Schwab; Arnd Doerfler
Journal:  Eur Radiol       Date:  2009-04-07       Impact factor: 5.315

7.  Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

8.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

9.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

10.  Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders.

Authors: 
Journal:  Stroke       Date:  1989-10       Impact factor: 7.914

View more
  1 in total

1.  Efficacy of Proximal Aspiration Thrombectomy for Using Balloon-Tipped Guide Catheter in Acute Intracranial Internal Carotid Artery Occlusion.

Authors:  Yong-Won Kim; Dong-Hun Kang; Yang-Ha Hwang; Jaechan Park; Yong-Sun Kim
Journal:  J Korean Neurosurg Soc       Date:  2016-07-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.